Literature DB >> 604188

Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.

P G Wheeler, T Smith, C Golindano, A N Alam, S P Wilkinson, C J Edmonds, R Williams.   

Abstract

Total body potassium (40K) and leucocyte potassium measurements were carried out on 19 patients with stable but decompensated cirrhosis maintained on diuretics for previous ascites. Of 13 patients receiving spironolactone alone none had a total body potassium below the expected lower limit of normal, whereas, of six receiving additional frusemide, two had low values. The results for leucocyte potassium were in agreement and simultaneous measurements of leucocyte magnesium showed a close correlation, those with intracellular potassium depletion also having magnesium depletion. One such patient was treated with magnesium supplements without effect on the potassium, although intracellular magnesium was improved. It is concluded that spironolactone alone is the treatment of choice in the maintenance management of such patients; that additional potassium would be unnecessary; and that additional frusemide should be avoided if possible.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 604188      PMCID: PMC1411634          DOI: 10.1136/gut.18.9.683

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  BODY AND SERUM POTASSIUM IN LIVER DISEASE. I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS.

Authors:  T H CASEY; W H SUMMERSKILL; A L ORVIS
Journal:  Gastroenterology       Date:  1965-02       Impact factor: 22.682

2.  Observations in experimental magnesium depletion.

Authors:  R WHANG; L G WELT
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

3.  Exchangeable potassium in wasting, amyotrophy, heart-disease, and cirrhosis of the liver.

Authors:  C NAGANT DE DEUXCHAISNES; R A COLLET; R BUSSET; R S MACH
Journal:  Lancet       Date:  1961-04-01       Impact factor: 79.321

4.  Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia.

Authors:  A E READ; J LAIDLAW; R M HASLAM; S SHERLOCK
Journal:  Clin Sci       Date:  1959-08       Impact factor: 6.124

5.  Alterations in the body potassium content in cirrhosis of the liver.

Authors:  J K AIKAWA; J H FELTS; G T HARRELL
Journal:  Gastroenterology       Date:  1953-07       Impact factor: 22.682

6.  Potassium metabolism and diuretics administration in liver cirrhosis.

Authors:  P Vesin
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

7.  Leucocyte electrolytes in cardiac and non-cardiac patients receiving diuretics.

Authors:  R P Edmondson; R D Thomas; P J Hilton; J Patrick; N F Jones
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

8.  Magnesium deficiency in liver cirrhosis.

Authors:  P Lim; E Jacob
Journal:  Q J Med       Date:  1972-07

9.  The relation of total body potassium to height, weight, and age in normal adults.

Authors:  K Boddy; P C King; R Hume; E Weyers
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

10.  Magnesium deficiency in patients on long-term diuretic therapy for heart failure.

Authors:  P Lim; E Jacob
Journal:  Br Med J       Date:  1972-09-09
View more
  6 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

2.  Changes in the electrolyte content of leucocytes at different clinical stages of cirrhosis.

Authors:  A N Alam; P Wheeler; S P Wilkinson; L Poston; C Golindano; R Williamss
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

3.  Management of hepatic ascites.

Authors: 
Journal:  Br Med J       Date:  1978-01-14

4.  Magnesium-saving property of an aldosterone antagonist in the treatment of oedema of liver cirrhosis.

Authors:  P Lim; E Jacob
Journal:  Br Med J       Date:  1978-03-25

5.  Diuretic-associated hypomagnesaemia.

Authors:  J Sheehan; A White
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

6.  Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.

Authors:  T Dyckner; P O Wester; L Widman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.